Pharmaceutical News

RSS

FDA approves MedImmune's new refrigerated formulation of FluMist influenza virus vaccine

MedImmune has announced that the U.S. Food and Drug Administration (FDA) has approved the company's new refrigerated formulation of FluMist (Influenza Virus Vaccine Live, Intranasal) for use in helping to prevent influenza in healthy children and adults from 5 years to 49 years of age.

8 Jan 2007

New Medicare payment method for prescription drugs covered under Part B reducing spending

Medicare's new payment method for reimbursing physicians for prescription drugs under Part B has reduced spending, according to a report to Congress prepared by the Medicare Payment Advisory Commission, CQ HealthBeat reports.

7 Jan 2007

Less than 1% of eligible Arkansas residents pre-enroll in prescription drug discount program

Less than 1% of an estimated 400,000 Arkansas residents eligible for a state prescription drug discount program participated in the pre-enrollment period, the Arkansas Democrat-Gazette reports.

7 Jan 2007

China's Henan province bans abortion drugs

China's Henan province on Monday banned the sale of drugs for medical abortions in coordination with the province's efforts to maintain gender balance among infants, Xinhua/China Daily reports.

7 Jan 2007

HHS and BioCryst advance development of new influenza drug

HHS Secretary Mike Leavitt announced that the Department has awarded a $102.6 million, four-year contract to BioCryst Pharmaceuticals, Inc. for advanced development of their influenza antiviral drug, peramivir.

7 Jan 2007

FDA updates health claim for calcium and Vitamin D for osteoporosis

The Food and Drug Administration (FDA) is proposing to allow new claims on foods and dietary supplements containing calcium and Vitamin D to show their potential to reduce the risk of osteoporosis.

7 Jan 2007

Ranbaxy granted approval to manufacture Atenolol

Ranbaxy Laboratories has announced that the Company has received approval from the U.S. Food and Drug Administration (FDA) to manufacture and market Atenolol Tablets USP, 25 mg, 50 mg, and 100 mg.

2 Jan 2007

FDA announces tentative approval of generic Zoloft

Lupin Pharmaceuticals, Inc. announced that the U.S. Food and Drug Administration (FDA) has granted tentative approval for the Company's Abbreviated New Drug Application (ANDA) for Sertraline Hydrochloride Tablets, 25mg, 50mg and 100mg.

2 Jan 2007

Low-income Medicare beneficiaries will have trouble getting medications in January 2007

Some pharmacists and advocates have raised concerns that many low-income Medicare beneficiaries "will again have trouble getting medications next month, as they did in January of this year," when the Medicare prescription drug benefit began, the New York Times reports.

5 Dec 2006

Australia to provide Gardasil at no cost to girls and women ages 12 to 26

Australian Prime Minister John Howard on Wednesday announced that the government will provide about $342 million for a program that will offer Merck's human papillomavirus vaccine Gardasil at no cost to girls and women ages 12 to 26 living in the country, Bloomberg reports.

2 Dec 2006

New Hampshire to provide Gardasil at no cost to girls

New Hampshire Department of Health and Human Services officials on Wednesday announced plans to become the first state to provide Merck's human papillomavirus vaccine Gardasil at no cost to girls ages 11 to 18 as part of a state program that offers immunizations to minors, the AP/Nashua Telegraph reports.

2 Dec 2006

Cipla, Ranbaxy to cut pediatric antiretroviral drug prices

Indian pharmaceutical companies Cipla and Ranbaxy under an agreement with the Clinton Foundation will reduce the prices of 19 different pediatric antiretroviral drugs in 62 developing countries to an average of 45% less than what treatments currently cost in the countries, former President Clinton announced on Thursday ahead of World AIDS Day on Dec. 1, the AP/Forbes reports.

2 Dec 2006

Thai Health Ministry to issue compulsory license for Merck's HIV/AIDS drug Efavirenz

Thailand's Ministry Of Public Health on Wednesday announced plans to issue a compulsory license to produce a lower-cost version of Merck's antiretroviral drug Efavirenz, Reuters reports.

2 Dec 2006

Canada says warnings needed on bird flu drug Tamiflu

Canadian health authority Health Canada has requested that the manufacturer of the antiviral drug Tamiflu place warnings on it's labels of adverse effects.

1 Dec 2006

Roche says Tamiflu still number one drug for fighting bird flu

Drug giant Roche has denied there has been any new evidence that suggests resistance to its drug Tamiflu was on the increase.

29 Nov 2006

New bird flu drug will provide new line of defence

Flu experts say a new flu drug with the ability to kill deadly strains of bird flu promises to provide a much needed third option should a pandemic occur.

28 Nov 2006

Target to expand discounted generic drug program to all pharmacies

The Minneapolis-based company said all of its 1,287 pharmacies now will offer a 30-day supply of certain generic drugs for $4. The company previously offered the program only in states where Wal-Mart was offering generic drugs at the same price (Reuters/New York Times, 11/21).

23 Nov 2006

Wal-Mart generic drug discount program indicates markets can provide medications at affordable prices

The generic prescription drug discount program introduced earlier this year by Wal-Mart Stores indicates that "markets are, in fact, capable of providing medicines at affordable prices," Peter Pitts, director of the Center for Medicine in the Public Interest and a former associate commissioner at FDA, writes in a Baltimore Sun opinion piece.

23 Nov 2006

Handbook on Developing pharmacy practice - A focus on patient care

The traditional role of pharmacists is to manufacture and supply medicines. More recently, pharmacists have been faced with increasing health demands: an ever-growing and complex range of medicines, and poor adherence to prescribed medicines, have forced the evolution of the pharmacist’s role into a more patient centred approach (known as pharmaceutical care).

23 Nov 2006

Federal Appeals Court agrees to rehear case on whether people should have access to experimental medications

The U.S. Court of Appeals for the District of Columbia on Tuesday vacated an earlier decision that would have provided terminally ill patients with expanded access to experimental medications and likely will rehear the case next summer, Dow Jones/Wall Street Journal reports (Wilde Mathews, Dow Jones/Wall Street Journal, 11/21).

23 Nov 2006

Pharmaceutical News

FDA approves MedImmune's new refrigerated formulation of FluMist influenza virus vaccine

New Medicare payment method for prescription drugs covered under Part B reducing spending

Less than 1% of eligible Arkansas residents pre-enroll in prescription drug discount program

China's Henan province bans abortion drugs

HHS and BioCryst advance development of new influenza drug

FDA updates health claim for calcium and Vitamin D for osteoporosis

Ranbaxy granted approval to manufacture Atenolol

FDA announces tentative approval of generic Zoloft

Low-income Medicare beneficiaries will have trouble getting medications in January 2007

Australia to provide Gardasil at no cost to girls and women ages 12 to 26

New Hampshire to provide Gardasil at no cost to girls

Cipla, Ranbaxy to cut pediatric antiretroviral drug prices

Thai Health Ministry to issue compulsory license for Merck's HIV/AIDS drug Efavirenz

Canada says warnings needed on bird flu drug Tamiflu

Roche says Tamiflu still number one drug for fighting bird flu

New bird flu drug will provide new line of defence

Target to expand discounted generic drug program to all pharmacies

Wal-Mart generic drug discount program indicates markets can provide medications at affordable prices

Handbook on Developing pharmacy practice - A focus on patient care

Federal Appeals Court agrees to rehear case on whether people should have access to experimental medications

AI in Healthcare: How generative tools are transforming clinical practice

The future of automation: Machine learning–driven hepatocyte and organoid counting

From street to lab: Advancing controlled substance testing with handheld Raman and FTIR

Latest News